$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmaceutical delivery system 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-009/32
  • A61K-031/60
출원번호 US-0640951 (1984-08-15)
우선권정보 GB-0022007 (1983-08-16)
발명자 / 주소
  • Baker Richard W. (Mountain View CA) Brooke James W. (Sisters OR)
출원인 / 주소
  • Burroughs Wellcome Co. (Research Triangle Park NC 02)
인용정보 피인용 횟수 : 149  인용 특허 : 9

초록 ▼

A composition for use in an aqueous environment which comprise a formulation containing a water-soluble pharmaceutically beneficial agent, a water-insoluble, water-permeable film coating surrounding the formulation, and particulate, water-soluble, pore-forming material dispersed within the film coat

대표청구항 ▼

A tablet comprising a core containing the admixture of a water-soluble medicine and a water-soluble osmotic enhancing agent in an amount by weight about equal to or greater than the weight of the medicine, said core having a water-insoluble, water-permeable coating surrounding said core, said coatin

이 특허에 인용된 특허 (9)

  1. Lindahl, Ake R.; Erlandsson, Stig A. B., Membrane-coated sustained-release tablets and method.
    상세보기
  2. Edgren David (El Granada CA), Osmotic device with wall comprising cellulose ether and permeability enhancer.
    상세보기
  3. Higuchi Takeru (Lawrence KS), Osmotic drug delivery system.
    상세보기
  4. Theeuwes Felix (Los Altos CA) Damani Nalinkant C. (Sunnyvale CA), Osmotically driven active agent dispenser.
    상세보기
  5. Powell, David R.; Patel, Vithal K., Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range.
    상세보기
  6. Dempski Robert E. (Dresher PA) Mehta Gunvant N. (Lansdale PA) Saboe Joseph C. (Norristown PA), Sustained release indomethacin.
    상세보기
  7. Guley Paul C. (Plattsburgh NY) DeNeale Richard J. (Willsboro NY) Milosovich George (Rouses Point NY), Sustained release pharmaceutical compositions.
    상세보기
  8. Groppenbacher Gregor (Mannheim-Feudenheim DT) Rieckmann Peter (Mannheim-Waldhof DT) Rothe Werner (Hockenheim DT), Tablets coated with aqueous resin dispersions.
    상세보기
  9. Harwood Richard J. (Bensalem PA) Bondi Joseph V. (Collegeville PA), Water and drug delivery system for suppository use.
    상세보기

이 특허를 인용한 특허 (149)

  1. Fletcher Allan,GBX ; Knutsen Lars Jacob Stray,GBX ; Porter Richard H. P.,GBX ; Weiss Scott Murray,GBX ; Shepherd Robin,GBX, (-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders.
    상세보기
  2. Arne, Lawrence; Au-Yeung, Kit Yee; Crandall, Kenneth C.; Robertson, Timothy, Active signal processing personal health signal receivers.
    상세보기
  3. Arne, Lawrence; Au-Yeung, Kit Yee; Crandall, Kenneth C.; Robertson, Timothy, Active signal processing personal health signal receivers.
    상세보기
  4. Arne, Lawrence; Au-Yeung, KitYee; Crandall, Kenneth C.; Robertson, Timothy, Active signal processing personal health signal receivers.
    상세보기
  5. Zebala, John A., Aminopterin dosage forms.
    상세보기
  6. Robertson, Timothy; Moon, Gregory; Ionescu, Arna; Behzadi, Yashar; O'Reilly, David; Filner, Aaron; Karplus, Erika; Cojuangco, Danielle; Burgess, Sara, Apparatus, system, and method for managing adherence to a regimen.
    상세보기
  7. Jani, Nilay; Webb, Douglas; Withrington, Jonathan; Berkman, Jeffrey; Li, Haifeng, Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device.
    상세보기
  8. Cardinal John R. (Old Lyme CT) Herbig Scott M. (Bend OR) Korsmeyer Richard W. (East Lyme CT) Lo Jeelin (Old Lyme CT) Smith Kelly L. (Bend OR) Thombre Avinash G. (Gales Ferry CT), Asymmetric membranes in delivery devices.
    상세보기
  9. Tabuteau, Herriot, Bupropion as a modulator of drug activity.
    상세보기
  10. Tabuteau, Herriot, Bupropion as a modulator of drug activity.
    상세보기
  11. Tabuteau, Herriot, Bupropion as a modulator of drug activity.
    상세보기
  12. Tabuteau, Herriot, Bupropion as a modulator of drug activity.
    상세보기
  13. Tabuteau, Herriot, Bupropion as a modulator of drug activity.
    상세보기
  14. Tabuteau, Herriot, Bupropion as a modulator of drug activity.
    상세보기
  15. Qun Kevin Fang ; Chrisantha Hugh Senanayake ; Paul Grover, Bupropion metabolites and methods of use.
    상세보기
  16. Thomas P. Jerussi ; John R. McCullough ; Chrisantha H. Senanayake ; Qun K. Fang, Bupropion metabolites and methods of use.
    상세보기
  17. Chopra, Sham, Chemical delivery device.
    상세보기
  18. Maneval, Daniel C.; Shepard, H. Michael; Thompson, Curtis B., Combination therapy with an anti-hyaluronan agent and therapeutic agent.
    상세보기
  19. Maneval, Daniel C.; Shepard, H. Michael; Thompson, Curtis B., Combination therapy with an anti-hyaluronan agent and therapeutic agent.
    상세보기
  20. Hafezi, Hooman; O'Reilly, David; Johnson, Patricia; Hatamkhany, Zahedeh; Robertson, Timothy; Zdeblick, Mark, Communication system incorporated in a container.
    상세보기
  21. Hafezi, Hooman; O'Reilly, David; Johnson, Patricia; Hatamkhany, Zahedeh; Robertson, Timothy, Communication system incorporated in an ingestible product.
    상세보기
  22. Hafezi, Hooman; O'Reilly, David; Johnson, Patricia; Hatamkhany, Zahedeh; Robertson, Timothy, Communication system incorporated in an ingestible product.
    상세보기
  23. Frank, Jeremy; Bjeletich, Peter; Hafezi, Hooman; Azevedo, Robert; Duck, Robert; Pesic, Iliya; Costello, Benedict; Snyder, Eric, Communication system with enhanced partial power source and method of manufacturing same.
    상세보기
  24. Zdeblick, Mark; Robertson, Timothy; Pikelny, Aleksandr; Hafezi, Hooman, Communication system with partial power source.
    상세보기
  25. Zdeblick, Mark; Robertson, Timothy; Pikelny, Aleksandr; Hafezi, Hooman, Communication system with partial power source.
    상세보기
  26. Berkman, Jeffrey; Zdeblick, Mark; Johnson, Patricia; Hafezi, Hooman; Withrington, Jonathan, Communication system with remote activation.
    상세보기
  27. Berkman, Jeffrey; Zdeblick, Mark; Johnson, Patricia; Hafezi, Hooman; Withrington, Jonathan, Communication system with remote activation.
    상세보기
  28. Tabuteau, Herriot, Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan.
    상세보기
  29. Tabuteau, Herriot, Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan.
    상세보기
  30. Tabuteau, Herriot, Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan.
    상세보기
  31. Tabuteau, Herriot, Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan.
    상세보기
  32. Tabuteau, Herriot, Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan.
    상세보기
  33. Tabuteau, Herriot, Compositions and methods for increasing dextromethorphan plasma levels and related pharmacodynamic effects.
    상세보기
  34. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  35. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  36. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  37. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  38. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  39. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  40. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  41. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  42. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  43. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  44. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  45. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  46. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  47. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects.
    상세보기
  48. Tabuteau, Herriot, Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects.
    상세보기
  49. Tabuteau, Herriot, Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects.
    상세보기
  50. Tabuteau, Herriot, Compositions and methods of using threohydroxybupropion for therapeutic purposes.
    상세보기
  51. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  52. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  53. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  54. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  55. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  56. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  57. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  58. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  59. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  60. Thanos, Christopher D.; Wang, Lin; Shepard, H. Michael, Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same.
    상세보기
  61. Thompson, Andrew, Container with electronically controlled interlock.
    상세보기
  62. Hafezi, Hooman; Robertson, Timothy; Colliou, Olivier; Zdeblick, Mark, Controlled activation ingestible identifier.
    상세보기
  63. Hafezi, Hooman; Robertson, Timothy; Colliou, Olivier; Zdeblick, Mark, Controlled activation ingestible identifier.
    상세보기
  64. Zentner Gaylen M. (Lawrence KS) Rork Gerald S. (Lawrence KS) Himmelstein Kenneth J. (Irvine CA), Controlled porosity osmotic pump.
    상세보기
  65. Staniforth John N. (Bath GB2), Controlled release device with an impermeable coating having an orifice for release of drug.
    상세보기
  66. Stead James A. (Swindon GB3) Nabahi Shore (Swindon GB3), Controlled release means.
    상세보기
  67. Li, Boyong; Nangia, Avinash; Chen, Chih Ming, Controlled release oral dosage form.
    상세보기
  68. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
    상세보기
  69. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
    상세보기
  70. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
    상세보기
  71. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
    상세보기
  72. Lee, Hun Joo; Lim, Jung Youl; Jung, Yong Woo; Lim, Bum Hyun; Shim, Kwang Hyun; Choi, Jin Sung; Yang, Kwang Ho; Kim, Hyun Bin, Database cache system.
    상세보기
  73. Blum, Alvin S., Delayed release aspirin for vascular obstruction prophylaxis.
    상세보기
  74. Seth Pawan, Delayed release coated tablet of bupropion hydrochloride.
    상세보기
  75. Prater, Derek Allan; Hassan, Mohammed; Bland, Christopher Robert, Delayed release pharmaceutical formulations.
    상세보기
  76. Shirvani, Alireza; Zdeblick, Mark; Withrington, Jonathan, Electromagnetic sensing and detection of ingestible event markers.
    상세보기
  77. Franz Robert M. (8712 Mariner Dr. Raleigh NC 27615), Film coated tablet of ranitidine HCl.
    상세보기
  78. Asari, Daisuke; Hori, Mitsuhiko; Shishido, Takuya, Film-form preparation.
    상세보기
  79. Asari, Daisuke; Hori, Mitsuhiko; Shishido, Takuya, Film-form preparation and method for producing the same.
    상세보기
  80. Hafezi, Hooman; Au-Yeung, Kityee; Duck, Robert; Holen, Maria Casillas; Robertson, Timothy; Costello, Benedict James, Highly reliable ingestible event markers and methods for using the same.
    상세보기
  81. Tabuteau, Herriot, Hydroxybupropion and related compounds as modulators of drug plasma levels.
    상세보기
  82. Shepard, H. Michael; Li, Xiaoming; Thompson, Curtis, Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods.
    상세보기
  83. Rodstrom, Theron Robert, Implantable drug delivery system.
    상세보기
  84. Colliou, Olivier; Robertson, Timothy; Zdeblick, Mark, In-body device having a multi-directional transmitter.
    상세보기
  85. Robertson, Timothy; Zdeblick, Mark, In-body device having deployable antenna.
    상세보기
  86. Hafezi, Hooman; Costello, Benedict James; Robertson, Timothy L.; Casillas Holen, Maria, In-body device with virtual dipole signal amplification.
    상세보기
  87. Hafezi, Hooman; Costello, Benedict; Robertson, Timothy; Holen, Maria Casillas, In-body device with virtual dipole signal amplification.
    상세보기
  88. Hafezi, Hooman; Robertson, Timothy; Snyder, Eric; Cozad, Brad, In-body power source having high surface area electrode.
    상세보기
  89. Hafezi, Hooman; Snyder, Eric J.; Costello, Benedict, Ingestible circuitry.
    상세보기
  90. Hafezi, Hooman; Snyder, Eric J.; Costello, Benedict, Ingestible circuitry.
    상세보기
  91. Hafezi, Hooman; Schmidt, Raymond, Ingestible device with pharmaceutical product.
    상세보기
  92. Duck, Robert; Savage, George; Johnson, Patricia; Zdeblick, Mark; Costello, Benedict; Au-Yeung, Kityee; Robertson, Timothy; Hafezi, Hooman, Ingestible event markers comprising an ingestible component.
    상세보기
  93. Jensen, Marc; Leichner, Robert; Beaulieu, Patrick; Au-Yeung, Kit Yee; Arne, Lawrence; Zdeblick, Mark; Thompson, Andrew; Savage, George; Robertson, Timothy; Behzadi, Yashar, Ingestion-related biofeedback and personalized medical therapy method and system.
    상세보기
  94. Hafezi, Hooman; Duck, Robert; Robertson, Timothy; Costello, Benedict, Integrated ingestible event marker system with pharmaceutical product.
    상세보기
  95. Sancoff Gregory E. (Rancho Santa Fe CA) Doyle Mark C. (San Diego CA), Liquid delivery device.
    상세보기
  96. Arne, Lawrence; Zdeblick, Mark; Dua, Aditya; Savage, George; Leichner, Robert; Shenasa, Jafar; Johnson, Patricia; Schmidt, Raymond; Hatamkhany, Zahedeh; Muralidharan, Veeraperurnanallu, Masticable ingestible product and communication system therefor.
    상세보기
  97. Schmidt, Raymond; Johnson, Patricia; Holen, Maria; Huang, Richard; Thai, Alvin, Metal detector apparatus, system, and method.
    상세보기
  98. James W. Young, Method for treating depression using optically pure (-)-bupropion.
    상세보기
  99. Lickrish, David; Zhang, Feng, Method of treatment of attention deficit hyperactivity disorder.
    상세보기
  100. John R. McCullough ; Paul D. Rubin, Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (+)-bupropion.
    상세보기
  101. John R. McCullough ; Paul D. Rubin, Methods and compositions for treating chronic disorders using optically pure (+)-bupropion.
    상세보기
  102. Lickrish, David; Zhang, Feng, Methods and compositions for treatment of attention deficit disorder.
    상세보기
  103. Chow, San-Laung; Wong, David; Garcia, Damian, Methods and formulations for making pharmaceutical compositions containing bupropion.
    상세보기
  104. Young James W., Methods for treating Parkinson's disease using optically pure (-)-bupropion.
    상세보기
  105. James W. Young, Methods for treating depression and other disorders using optically pure (-)-bupropion.
    상세보기
  106. Young James W., Methods for treating obesity and weight gain using optically pure (-)-bupropion.
    상세보기
  107. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
    상세보기
  108. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
    상세보기
  109. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
    상세보기
  110. Tabuteau, Herriot, Methods of modulating drug plasma levels using erythrohydroxybupropion.
    상세보기
  111. Lickrish, David; Zhang, Feng, Methods of treatment of attention deficit hyperactivity disorder.
    상세보기
  112. Legrand, Valérie; Castan, Catherine; Meyrueix, Rémi; Soula, Gérard, Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles.
    상세보기
  113. Robertson, Timothy; Hafezi, Hooman; Schmidt, Raymond, Miniature ingestible device.
    상세보기
  114. Robertson, Timothy; Hafezi, Hooman; Schmidt, Raymond, Miniature ingestible device.
    상세보기
  115. Zdeblick, Mark; Stoll, Arna Ionescu; McAllister, William; Au-Yeung, Kit Yee, Mobile device and system for detection and communication of information received from an ingestible device.
    상세보기
  116. Oberegger, Werner; Zhou, Fang; Maes, Paul; Jackson, Graham; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
    상세보기
  117. Oberegger, Werner; Zhou, Fang; Maes, Paul; Turchetta, Stefano; Jackson, Graham; Massardo, Pietro; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
    상세보기
  118. Oberegger, Werner; Zhou, Fang; Maes, Paul; Turchetta, Stefano; Jackson, Graham; Massardo, Pietro; Saleh, Mohammad Ashty, Modified-release formulations of a bupropion salt.
    상세보기
  119. Robertson, Timothy; Zdeblick, Mark, Multi-mode communication ingestible event markers and systems, and methods of using the same.
    상세보기
  120. Robertson, Timothy; Zdeblick, Mark, Multi-mode communication ingestible event markers and systems, and methods of using the same.
    상세보기
  121. Asari, Daisuke; Hori, Mitsuhiko; Ogawa, Keiko, Oral film-form base and oral film-form preparation.
    상세보기
  122. Asari, Daisuke; Hori, Mitsuhiko; Ogawa, Keiko, Oral film-form base and oral film-form preparation.
    상세보기
  123. Asari, Daisuke; Hori, Mitsuhiko; Shishido, Takuya, Oral film-form base and preparation.
    상세보기
  124. Rudnic Edward M. ; Burnside Beth A. ; Flanner Henry H. ; Wassink Sandra E. ; Couch Richard A. ; Pinkett Jill E., Osmotic drug delivery system.
    상세보기
  125. Rudnic, Edward M.; Burnside, Beth A.; Flanner, Henry H.; Wassink, Sandra E.; Couch, Richard A.; Pinkett, Jill E., Osmotic drug delivery system.
    상세보기
  126. Zdeblick, Mark J.; Thompson, Andrew; Savage, George M., Patient customized therapeutic regimens.
    상세보기
  127. Zdeblick, Mark; Pikelny, Aleksandr; Robertson, Timothy; Hafezi, Hooman, Pharma-informatics system.
    상세보기
  128. Zdeblick, Mark; Thompson, Andrew; Pikelny, Aleksandr; Robertson, Timothy; Hafezi, Hooman, Pharma-informatics system.
    상세보기
  129. Zdeblick, Mark; Thompson, Andrew; Pikelny, Aleksandr; Robertson, Timothy; Hafezi, Hooman, Pharma-informatics system.
    상세보기
  130. Hafezi, Hooman; Moon, Gregory; Au-Yeung, Kityee; Duck, Robert; Holen, Maria Casillas, Pharmaceutical dosages delivery system.
    상세보기
  131. Ascher,John A.; Johnston,Joseph Andrews; Learned Coughlin,Susan Marie; Bye,Alan, Pharmaceutically active morpholinol.
    상세보기
  132. Broom, Toby; Delpogetto, Monica; Atkins, Richard; Negus, Alan; Oxley, Paul William, Pharmaceutically active morpholinol.
    상세보기
  133. Musso,David Lee, Pharmaceutically active morpholinol.
    상세보기
  134. Partridge, John Joseph, Pharmaceutically active morpholinol.
    상세보기
  135. Robertson, Timothy L.; Behzadi, Yashar, Probablistic pharmacokinetic and pharmacodynamic modeling.
    상세보기
  136. Thompson, Andrew; Thompson, Todd; Behzadi, Yashar; Abraham, Danielle Cojuangco; Duck, Robert; Ionescu, Arna; Lee, Ray; Suchan, Robin; Turner, William; Muralidharan, Veeraperumanallu; Karplus, Erika; Savage, George, Social media networking based on physiologic information.
    상세보기
  137. Edward M. Rudnic ; Beth A. Burnside ; Henry H. Flanner ; Sandra E. Wassink ; Richard A. Couch ; Jill E. Pinkett, Soluble form osmotic dose delivery system.
    상세보기
  138. Rudnic Edward M. ; Burnside Beth A. ; Flanner Henry H. ; Wassink Sandra E. ; Couch Richard A. ; Pinkett Jill E., Soluble form osmotic dose delivery system.
    상세보기
  139. Ruff Michael D. ; Kalidindi Sanvasi R. ; Sutton ; Jr. Joel Elmore, Stabilized pharmaceutical.
    상세보기
  140. Ruff Michael David ; Kalidindi Sanyasi Raju ; Sutton ; Jr. Joel Elmore, Stabilized pharmaceutical composition containing bupropion.
    상세보기
  141. Derrieu Guy (Cagnes sur Mer FRX) Raynier Bernard (Nice FRX), Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications.
    상세보기
  142. Li, Boyong; Cheng, Xiu Xiu, Stable pharmaceutical compositions without a stabilizer.
    상세보기
  143. Li, Boyong; Cheng, Xiu Xiu, Stable pharmaceutical compositions without a stabilizer.
    상세보기
  144. Behzadi, Yashar, State characterization based on multi-variate data fusion techniques.
    상세보기
  145. Zdeblick, Mark J., System for supply chain management.
    상세보기
  146. Costello, Benedict; Robertson, Timothy; Johnson, Patricia; Duck, Robert; Huang, Richard; Nicholas, Rod; Cozad, Brad; Hafezi, Hooman; Scheinpflug, Kurt; Hatamkhany, Zahedeh, Techniques for manufacturing ingestible event markers comprising an ingestible component.
    상세보기
  147. Fletcher, Allan; Shepherd, Robin, Use of (+)mefloquine for the treatment of malaria.
    상세보기
  148. Cardinal John R. (Groton CT) Herbig Scott M. (Groton CT) Korsmeyer Richard W. (Groton CT) Lo Jeelin (Groton CT) Smith Kelly L. (Groton CT) Thombre Avinash G. (Groton CT), Use of asymmetric membranes in delivery devices.
    상세보기
  149. Herbig Scott Max ; Korsmeyer Richard Wilker ; Thombre Avinash Govind, Use of interfacially-polymerized membranes in delivery devices.
    상세보기

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로